Evaluation and Management of Dementia

doi:10.1017/9781108942751.011

Chapter 11 - Evaluation and Management of Dementia

from Section II - Geriatric Syndromes

Published online by Cambridge University Press: 30 June 2022

Carol K. Chan and

Constantine G. Lyketsos

Edited by

Jan Busby-Whitehead ,

Mary H. Palmer and

Jan Busby-Whitehead: Affiliation:
University of North Carolina, Chapel Hill
Samuel C. Durso: Affiliation:
The Johns Hopkins University, Maryland
Christine Arenson: Affiliation:
Thomas Jefferson University, Philadelphia
Rebecca Elon: Affiliation:
The Johns Hopkins University School of Medicine
Mary H. Palmer: Affiliation:
University of North Carolina, Chapel Hill
William Reichel: Affiliation:
Georgetown University Medical Center

Book contents

Get access

Summary

Dementia is a clinical syndrome characterized by global cognitive decline, involving deficits in memory and at least one other area of cognition, and affects over 47 million persons worldwide. While Alzheimer’s dementia is the most common cause, it commonly co-occurs with other dementia-related pathologies such as cerebrovascular disease and Lewy body disease. The evaluation and differential diagnosis of dementia involves history taking with outside informants, thorough medication review, examination focused on phenomenology and associated features, and a workup for potential causes. Depression and delirium due to other medical causes may overlap with symptoms of dementia, and should be considered in a dementia evaluation. The four pillars of dementia care are: (1) disease-oriented treatment, (2) symptomatic treatments, (3) supportive care for the patient, and (4) supportive care for the caregiver. Management usually involves psychological, social, and environmental adjustments. Disease-modifying pharmacotherapy for dementia is still under development, and has largely been unsuccessful. Although symptomatic treatments such as cholinesterase inhibitors and memantine are available, they provide a modest and temporary stabilization of cognitive changes associated with the disease, and do not reverse or stop the degenerative process.

Keywords

dementia neuropsychiatric symptoms diagnosis therapy Alzheimer’s disease cholinesterase inhibitors memantine neuroimaging neuropsychological test

Type: Chapter
Information: Reichel's Care of the Elderly
Clinical Aspects of Aging
, pp. 112 - 128

DOI: https://doi.org/10.1017/9781108942751.011 [Opens in a new window]

Publisher: Cambridge University Press

Print publication year: 2022

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Aarsland, D, Zaccai, J, Brayne, C. A systematic review of prevalence studies of dementia in Parkinson’s disease. Mov. Disord. Off. J. Mov. Disord. Soc. 2005; 20:1255–1263. https://doi.org/10.1002/mds.20527.Google Scholar

Alzheimer’s Association. 2019 Alzheimer’s disease facts and figures. Alzheimers Dement. 2019; 15:321–387.Google Scholar

American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (DSM-5®). Washington, DC: American Psychiatric Association, 2013.Google Scholar

Appleby, BS, Lyketsos, CG. Rapidly progressive dementias and the treatment of human prion diseases. Expert Opin. Pharmacother. 2011; 12:1–12.Google Scholar

Bang, J, Spina, S, Miller, BL. Frontotemporal dementia. Lancet Lond. Engl. 2015; 386:1672–1682. https://doi.org/10.1016/S0140-6736(15)00461-4.Google Scholar

Baumgart, M, Snyder, HM, Carrillo, MC, Fazio, S, Kim, H, Johns, H. Summary of the evidence on modifiable risk factors for cognitive decline and dementia: A population-based perspective. Alzheimers Dement. 2015; 11:718–726. https://doi.org/10.1016/j.jalz.2015.05.016.Google Scholar

Bennett, JM, Chekaluk, E, Batchelor, J. Cognitive tests and determining fitness to drive in dementia: A systematic review. J. Am. Geriatr. Soc. 2016; 64:1904–1917. https://doi.org/10.1111/jgs.14180.CrossRef Google Scholar PubMed

Bertoux, M, Delavest, M, de Souza, LC, Funkiewiez, A, Lépine, J-P, Fossati, P, Dubois, B, Sarazin, M. Social cognition and emotional assessment differentiates frontotemporal dementia from depression. J. Neurol. Neurosurg. Psychiatry. 2012; 83:411–416. https://doi.org/10.1136/jnnp-2011-301849.Google Scholar

Burckhardt, M, Herke, M, Wustmann, T, Watzke, S, Langer, G, Fink, A. Omega-3 fatty acids for the treatment of dementia. Cochrane Database Syst. Rev. 2016; 4:CD009002. https://doi.org/10.1002/14651858.CD009002.pub3.Google Scholar PubMed

Chêne, G, Beiser, A, Au, R, Preis, SR, Wolf, PA, Dufouil, C, Seshadri, S. Gender and incidence of dementia in the Framingham Heart Study from mid-adult life. Alzheimers Dement. J. Alzheimers Assoc. 2015; 11:310–320. https://doi.org/10.1016/j.jalz.2013.10.005.Google Scholar

Chung, S-D, Liu, S-P, Sheu, J-J, Lin, C-C, Lin, H-C, Chen, C-H. Increased healthcare service utilizations for patients with dementia: A population-based study. PLOS ONE. 2014; 9:e105789. https://doi.org/10.1371/journal.pone.0105789.Google Scholar

Clarfield, AM. The decreasing prevalence of reversible dementias: An updated meta-analysis. Arch. Intern. Med. 2003; 163:2219–2229. https://doi.org/10.1001/archinte.163.18.2219.Google Scholar

Cummings, J, Ritter, A, Zhong, K. Clinical trials for disease-modifying therapies in Alzheimer’s disease: A primer, lessons learned, and a blueprint for the future. J. Alzheimers Dis. JAD. 2018; 64:S3–S22. https://doi.org/10.3233/JAD-179901.CrossRef Google Scholar

Cummings, JL, Isaacson, RS, Schmitt, FA, Velting, DM. A practical algorithm for managing Alzheimer’s disease: What, when, and why? Ann. Clin. Transl. Neurol. 2015; 2:307–323. https://doi.org/10.1002/acn3.166.Google Scholar

Dawson, JD, Anderson, SW, Uc, EY, Dastrup, E, Rizzo, M. Predictors of driving safety in early Alzheimer disease. Neurology. 2009; 72:521–527.Google Scholar

Doraiswamy, PM, Leon, J, Cummings, JL, Marin, D, Neumann, PJ. Prevalence and impact of medical comorbidity in Alzheimer’s disease. J. Gerontol. A. Biol. Sci. Med. Sci. 2002; 57:M173–177. https://doi.org/10.1093/gerona/57.3.m173.Google Scholar

Dubinsky, RM, Stein, AC, Lyons, K. Practice parameter: risk of driving and Alzheimer’s disease (an evidence-based review): Report of the quality standards subcommittee of the American Academy of Neurology. Neurology. 2000; 54:2205–2211.Google Scholar

Duthie, A, Chew, D, Soiza, RL. Non-psychiatric comorbidity associated with Alzheimer’s disease. QJM Mon. J. Assoc. Physicians. 2011; 104:913–920. https://doi.org/10.1093/qjmed/hcr118.CrossRef Google Scholar PubMed

Eggenberger, E, Heimerl, K, Bennett, MI. Communication skills training in dementia care: A systematic review of effectiveness, training content, and didactic methods in different care settings. Int. Psychogeriatr. 2013; 25:345–358. https://doi.org/10.1017/S1041610212001664.Google Scholar

Emre, M, Aarsland, D, Brown, R, et al. Clinical diagnostic criteria for dementia associated with Parkinson’s disease. Mov. Disord. Off. J. Mov. Disord. Soc. 2007; 22:1689–1707; quiz 1837. https://doi.org/10.1002/mds.21507.CrossRef Google Scholar PubMed

Etters, L, Goodall, D, Harrison, BE. Caregiver burden among dementia patient caregivers: A review of the literature. J. Am. Acad. Nurse Pract. 2008; 20:423–428. https://doi.org/10.1111/j.1745-7599.2008.00342.x.Google Scholar

Farrimond, LE, Roberts, E, McShane, R. Memantine and cholinesterase inhibitor combination therapy for Alzheimer’s disease: A systematic review. BMJ Open. 2012; 2. https://doi.org/10.1136/bmjopen-2012-000917.Google Scholar

Filippi, M, Agosta, F, Barkhof, F, et al. European Federation of the Neurologic Societies, EFNS task force: The use of neuroimaging in the diagnosis of dementia. Eur. J. Neurol. 2012; 19:e131–140, 1487–1501. https://doi.org/10.1111/j.1468-1331.2012.03859.x.Google Scholar

Folstein, MF, Folstein, SE, McHugh, PR. “Mini-mental state”: A practical method for grading the cognitive state of patients for the clinician. J. Psychiatr. Res. 1975; 12:189–198. https://doi.org/10.1016/0022-3956(75)90026-6.CrossRef Google Scholar PubMed

Gatz, M, Reynolds, CA, Fratiglioni, L, et al. Role of genes and environments for explaining Alzheimer disease. Arch. Gen. Psychiatry. 2006; 63:168–174. https://doi.org/10.1001/archpsyc.63.2.168.CrossRef Google Scholar PubMed

Geda, YE, Schneider, LS, Gitlin, LN, et al. Neuropsychiatric Syndromes Professional Interest Area of ISTAART. Neuropsychiatric symptoms in Alzheimer’s disease: Past progress and anticipation of the future. Alzheimers Dement. J. Alzheimers Assoc. 2013; 9:602–608. https://doi.org/10.1016/j.jalz.2012.12.001.Google Scholar

Geschwind, MD, Haman, A, Miller, BL. Rapidly progressive dementia. Neurol. Clin. Dementia. 2007; 25:783–807. https://doi.org/10.1016/j.ncl.2007.04.001.Google Scholar

Glinz, D, Gloy, VL, Monsch, AU, et al. Acetylcholinesterase inhibitors combined with memantine for moderate to severe Alzheimer’s disease: A meta-analysis. Swiss Med. Wkly. 2019; 149:w20093. https://doi.org/10.4414/smw.2019.20093.Google Scholar

Gorno-Tempini, ML, Hillis, AE, Weintraub, S, et al. Classification of primary progressive aphasia and its variants. Neurology. 2011; 76:1006–1014.Google Scholar

Gower, LEJ, Gatewood, MO, Kang, CS. Emergency department management of delirium in the elderly. West. J. Emerg. Med. 2012; 13:194–201. https://doi.org/10.5811/westjem.2011.10.6654.Google Scholar

Groves, WC, Brandt, J, Steinberg, M, et al. Vascular dementia and Alzheimer’s disease: Is there a difference? A comparison of symptoms by disease duration. J. Neuropsychiatry Clin. Neurosci. 2000; 12(3):305–315.CrossRef Google Scholar

Hamilton, JM, Landy, KM, Salmon, DP, et al. Early visuospatial deficits predict the occurrence of visual hallucinations in autopsy-confirmed dementia with Lewy bodies. Am. J. Geriatr. Psychiatry Off. J. Am. Assoc. Geriatr. Psychiatry. 2012; 20:773–781. https://doi.org/10.1097/JGP.0b013e31823033bc.CrossRef Google Scholar PubMed

Harrison Dening, K, Sampson, EL, De Vries, K. Advance care planning in dementia: Recommendations for healthcare professionals. Palliat. Care Res. Treat. 2019; 12:1178224219826579.Google Scholar

Inouye, SK, Westendorp, RGJ, Saczynski, JS. Delirium in elderly people. Lancet Lond. Engl. 2014; 383:911–922. https://doi.org/10.1016/S0140-6736(13)60688-1.CrossRef Google Scholar PubMed

Joe, E, Ringman, JM, Cognitive symptoms of Alzheimer’s disease: Clinical management and prevention. BMJ. 2019; 367:l6217. https://doi.org/10.1136/bmj.l6217.Google Scholar

Kales, HC, Gitlin, LN, Lyketsos, CG. Management of neuropsychiatric symptoms of dementia in clinical settings: Recommendations from a multidisciplinary expert panel. J. Am. Geriatr. Soc. 2014; 62:762–769.Google Scholar

Kukull, WA, Larson, EB, Teri, L, et al. The mini-mental state examination score and the clinical diagnosis of dementia. J. Clin. Epidemiol. 1994; 47:1061–1067. https://doi.org/10.1016/0895-4356(94)90122-8.Google Scholar

Liu, CC, Liu, CC, Kanekiyo, T, et al. Apolipoprotein E and Alzheimer disease: Risk, mechanisms and therapy. Nat. Rev. Neurol. 2013; 9:106–118. https://doi.org/10.1038/nrneurol.2012.263.Google Scholar

Livingston, G, Sommerlad, A, Orgeta, V, et al. Dementia prevention, intervention, and care. The Lancet. 2017; 390:2673–2734. https://doi.org/10.1016/S0140-6736(17)31363-6.Google Scholar

Lyketsos, CG, Colenda, CC, Beck, C, et al. Position statement of the American Association for Geriatric Psychiatry regarding principles of care for patients with dementia resulting from Alzheimer disease. Am. J. Geriatr. Psychiatry. 2006; 14:561–573.Google Scholar

Marioni, RE, Proust-Lima, C, Amieva, H, et al. Social activity, cognitive decline and dementia risk: A 20-year prospective cohort study. BMC Public Health. 2015; 15:1089. https://doi.org/10.1186/s12889-015-2426-6.Google Scholar

Matsunaga, S, Kishi, T, Iwata, N. Combination therapy with cholinesterase inhibitors and memantine for Alzheimer’s disease: A systematic review and meta-analysis. Int. J. Neuropsychopharmacol. 2015; 18. https://doi.org/10.1093/ijnp/pyu115.Google Scholar

McKeith, IG, Boeve, BF, Dickson, DW, et al. Diagnosis and management of dementia with Lewy bodies. Neurology. 2017; 89:88–100. https://doi.org/10.1212/WNL.0000000000004058.Google Scholar

McKhann, GM, Knopman, DS, Chertkow, H, et al. The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement. 2011; 7:263–269.Google Scholar

Mielke, MM, Rosenberg, PB, Tschanz, J, et al. Vascular factors predict rate of progression in Alzheimer disease. Neurology. 2007; 69:1850–1858. https://doi.org/10.1212/01.wnl.0000279520.59792.fe.Google Scholar

Muangpaisan, W, Petcharat, C, Srinonprasert, V. Prevalence of potentially reversible conditions in dementia and mild cognitive impairment in a geriatric clinic. Geriatr. Gerontol. Int. 2012; 12:59–64. https://doi.org/10.1111/j.1447-0594.2011.00728.x.Google Scholar

Nasreddine, ZS, Phillips, NA, Bédirian, V, et al. The Montreal Cognitive Assessment, MoCA: A brief screening tool for mild cognitive impairment. J. Am. Geriatr. Soc. 2005; 53:695–699. https://doi.org/10.1111/j.1532-5415.2005.53221.x.Google Scholar

Norton, S, Matthews, FE, Barnes, DE, et al. Potential for primary prevention of Alzheimer’s disease: An analysis of population-based data. Lancet Neurol.2014; 13:788–794. https://doi.org/10.1016/S1474-4422(14)70136-X.Google Scholar

O’Brien, JT, Thomas, A. Vascular dementia. The Lancet. 2015; 386:1698–1706. https://doi.org/10.1016/S0140-6736(15)00463-8.Google Scholar

Okamura, N, Harada, R, Furukawa, K, et al. Advances in the development of tau PET radiotracers and their clinical applications. Ageing Res. Rev. 2016; 30:107–113. https://doi.org/10.1016/j.arr.2015.12.010.Google Scholar

Paterson, RW, Takada, LT, Geschwind, MD. Diagnosis and treatment of rapidly progressive dementias. Neurol. Clin. Pract. 2012; 2:187–200. https://doi.org/10.1212/CPJ.0b013e31826b2ae8.Google Scholar

Phan, SV, Osae, S, Morgan, JC, et al. Neuropsychiatric symptoms in dementia: Considerations for pharmacotherapy in the USA. Drugs RD. 2019; 19:93–115. https://doi.org/10.1007/s40268-019-0272-1.Google Scholar

Rodda, J, Carter, J. Cholinesterase inhibitors and memantine for symptomatic treatment of dementia. BMJ. 2012; 344. https://doi.org/10.1136/bmj.e2986.Google Scholar

Rosen, T, Connors, S, Clark, S, et al. Assessment and management of delirium in older adults in the emergency department: Literature review to inform development of a novel clinical protocol. Adv. Emerg. Nurs. J. 2015; 37:183–E3. https://doi.org/10.1097/TME.0000000000000066.Google Scholar

Sorbi, S, Hort, J, Erkinjuntti, T, et al. EFNS-ENS Guidelines on the diagnosis and management of disorders associated with dementia. Eur. J. Neurol. 2012; 19:1159–1179. https://doi.org/10.1111/j.1468-1331.2012.03784.x.Google Scholar

Steinman, MA, Hanlon, JT. Managing medications in clinically complex elders: “There’s got to be a happy medium.” JAMA. 2010; 304:1592–1601. https://doi.org/10.1001/jama.2010.1482.CrossRef Google Scholar PubMed

Tiraboschi, P, Salmon, DP, Hansen, LA, et al. What best differentiates Lewy body from Alzheimer’s disease in early-stage dementia? Brain J. Neurol. 2006; 129:729–735. https://doi.org/10.1093/brain/awh725.Google Scholar

Vandervoort, A, Houttekier, D, Vander Stichele, R, et al. Quality of dying in nursing home residents dying with dementia: Does advanced care planning matter? A nationwide postmortem study. PloS One. 2014; 9:e91130.Google Scholar

Vann Jones, SA, O’Brien, JT. The prevalence and incidence of dementia with Lewy bodies: A systematic review of population and clinical studies. Psychol. Med. 2014; 44:673–683. https://doi.org/10.1017/S0033291713000494.Google Scholar

Vieira, RT, Caixeta, L, Machado, S, et al. Epidemiology of early-onset dementia: A review of the literature. Clin. Pract. Epidemiol. Ment. Health CP EMH. 2013; 9:88–95. https://doi.org/10.2174/1745017901309010088.Google Scholar

Walker, Z, Possin, KL, Boeve, BF, Aarsland, D. Non-Alzheimer’s dementia 2. Lancet Lond. Engl. 2015; 386:1683–1697. https://doi.org/10.1016/S0140-6736(15)00462-6.Google Scholar

Weiner, M, Khachaturian, Z. The use of MRI and PET for clinical diagnosis of dementia and investigation of cognitive impairment: A consensus report. Alzheimer’s Assoc. Chic. IL. 2005; 1:1–15.Google Scholar

Williams-Gray, CH, Mason, SL, Evans, JR, et al. The CamPaIGN study of Parkinson’s disease: 10-year outlook in an incident population-based cohort. J. Neurol. Neurosurg. Psychiatry. 2013; 84:1258–1264. https://doi.org/10.1136/jnnp-2013-305277.Google Scholar

Xu, W, Tan, L, Wang, H-F, et al. Education and risk of dementia: Dose-response meta-analysis of prospective cohort studies. Mol. Neurobiol. 2016; 53:3113–3123. https://doi.org/10.1007/s12035-015-9211-5.Google Scholar

Zhao, Q-F, Tan, L, Wang, H-F, et al. The prevalence of neuropsychiatric symptoms in Alzheimer’s disease: Systematic review and meta-analysis. J. Affect. Disord. 2016; 190:264–271. https://doi.org/10.1016/j.jad.2015.09.069.Google Scholar

Blennow, K, Dubois, B, Fagan, AM, Lewczuk, P, de Leon, MJ, Hampel, H. Clinical utility of cerebrospinal fluid biomarkers in the diagnosis of early Alzheimer’s disease. Alzheimers Dement. 2015; 11(1):58–69.Google Scholar

Olsson, B, Lautner, R, Andreasson, U, Ohrfelt, A, Portelius, E, Bjerke, M, et al. CFS and blood biomarkers for the diagnosis of Alzheimer’s disease: A systematic review and meta-analysis. Lancet Neurol. 2016; 15:673–684.Google Scholar

Book contents

Chapter 11 - Evaluation and Management of Dementia

Summary

Keywords

Access options

References

Save book to Kindle

Save book to Dropbox

Save book to Google Drive